Cargando…

The National Clinical Care Commission Report to Congress: Summary and Next Steps

The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with mak...

Descripción completa

Detalles Bibliográficos
Autores principales: Conlin, Paul R., Boltri, John M., Bullock, Ann, Greenlee, M. Carol, Lopata, Aaron M., Powell, Clydette, Schillinger, Dean, Tracer, Howard, Herman, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887605/
https://www.ncbi.nlm.nih.gov/pubmed/36701591
http://dx.doi.org/10.2337/dc22-0622
_version_ 1784880376158617600
author Conlin, Paul R.
Boltri, John M.
Bullock, Ann
Greenlee, M. Carol
Lopata, Aaron M.
Powell, Clydette
Schillinger, Dean
Tracer, Howard
Herman, William H.
author_facet Conlin, Paul R.
Boltri, John M.
Bullock, Ann
Greenlee, M. Carol
Lopata, Aaron M.
Powell, Clydette
Schillinger, Dean
Tracer, Howard
Herman, William H.
author_sort Conlin, Paul R.
collection PubMed
description The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with making recommendations to leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC determined that diabetes cannot be addressed simply as a medical problem but must also be addressed as a societal problem requiring social, clinical, and public health policy solutions. As a result, the NCCC’s recommendations address policies and programs of both non–health-related and health-related federal agencies. The NCCC report, submitted to the U.S. Congress on 6 January 2022, makes 39 specific recommendations, including three foundational recommendations that non–health-related and health-related federal agencies coordinate their activities to better address diabetes, that all federal agencies and departments ensure that health equity is a guiding principle for their policies and programs that impact diabetes, and that all Americans have access to comprehensive and affordable health care. Specific recommendations are also made to improve general population-wide policies and programs that impact diabetes risk and control, to increase awareness and prevention efforts among those at high risk for type 2 diabetes, and to remove barriers to access to effective treatments for diabetes and its complications. Finally, the NCCC recommends that an Office of National Diabetes Policy be established to coordinate the activities of health-related and non–health-related federal agencies to address diabetes prevention and treatment. The NCCC urges Congress and the Secretary of Health and Human Services to implement these recommendations to protect the health and well-being of the more than 130 million Americans at risk for and living with diabetes.
format Online
Article
Text
id pubmed-9887605
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-98876052023-02-08 The National Clinical Care Commission Report to Congress: Summary and Next Steps Conlin, Paul R. Boltri, John M. Bullock, Ann Greenlee, M. Carol Lopata, Aaron M. Powell, Clydette Schillinger, Dean Tracer, Howard Herman, William H. Diabetes Care The National Clinical Care Commission Report to Congress The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with making recommendations to leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC determined that diabetes cannot be addressed simply as a medical problem but must also be addressed as a societal problem requiring social, clinical, and public health policy solutions. As a result, the NCCC’s recommendations address policies and programs of both non–health-related and health-related federal agencies. The NCCC report, submitted to the U.S. Congress on 6 January 2022, makes 39 specific recommendations, including three foundational recommendations that non–health-related and health-related federal agencies coordinate their activities to better address diabetes, that all federal agencies and departments ensure that health equity is a guiding principle for their policies and programs that impact diabetes, and that all Americans have access to comprehensive and affordable health care. Specific recommendations are also made to improve general population-wide policies and programs that impact diabetes risk and control, to increase awareness and prevention efforts among those at high risk for type 2 diabetes, and to remove barriers to access to effective treatments for diabetes and its complications. Finally, the NCCC recommends that an Office of National Diabetes Policy be established to coordinate the activities of health-related and non–health-related federal agencies to address diabetes prevention and treatment. The NCCC urges Congress and the Secretary of Health and Human Services to implement these recommendations to protect the health and well-being of the more than 130 million Americans at risk for and living with diabetes. American Diabetes Association 2023-02 2023-01-26 /pmc/articles/PMC9887605/ /pubmed/36701591 http://dx.doi.org/10.2337/dc22-0622 Text en © 2023 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
spellingShingle The National Clinical Care Commission Report to Congress
Conlin, Paul R.
Boltri, John M.
Bullock, Ann
Greenlee, M. Carol
Lopata, Aaron M.
Powell, Clydette
Schillinger, Dean
Tracer, Howard
Herman, William H.
The National Clinical Care Commission Report to Congress: Summary and Next Steps
title The National Clinical Care Commission Report to Congress: Summary and Next Steps
title_full The National Clinical Care Commission Report to Congress: Summary and Next Steps
title_fullStr The National Clinical Care Commission Report to Congress: Summary and Next Steps
title_full_unstemmed The National Clinical Care Commission Report to Congress: Summary and Next Steps
title_short The National Clinical Care Commission Report to Congress: Summary and Next Steps
title_sort national clinical care commission report to congress: summary and next steps
topic The National Clinical Care Commission Report to Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887605/
https://www.ncbi.nlm.nih.gov/pubmed/36701591
http://dx.doi.org/10.2337/dc22-0622
work_keys_str_mv AT conlinpaulr thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT boltrijohnm thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT bullockann thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT greenleemcarol thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT lopataaaronm thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT powellclydette thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT schillingerdean thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT tracerhoward thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT hermanwilliamh thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT conlinpaulr nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT boltrijohnm nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT bullockann nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT greenleemcarol nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT lopataaaronm nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT powellclydette nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT schillingerdean nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT tracerhoward nationalclinicalcarecommissionreporttocongresssummaryandnextsteps
AT hermanwilliamh nationalclinicalcarecommissionreporttocongresssummaryandnextsteps